TY  - JOUR
AU  - Tabák, Ádám G
AU  - Anderson, John
AU  - Aschner, Pablo
AU  - Liu, Minzhi
AU  - Saremi, Aramesh
AU  - Stella, Peter
AU  - Tinahones, Francisco J
AU  - Wysham, Carol
AU  - Meier, Juris J
PY  - 2019
DO  - 10.1007/s13300-019-00735-7
SN  - 1869-6953
UR  - http://hdl.handle.net/10668/14842
T2  - Diabetes therapy : research, treatment and education of diabetes and related disorders
AB  - Basal-bolus (BB) regimens are generally used to intensify basal insulin therapy in patients with type 2 diabetes (T2D) not meeting glycemic targets. However, drawbacks include multiple injection burden and risk of weight gain and hypoglycemia. A...
LA  - en
PB  - Springer
KW  - Hypoglycemia
KW  - Insulin therapy
KW  - Type 2 diabetes
KW  - Weight control
KW  - iGlarLixi
KW  - Insulin glargine
KW  - Diabetes mellitus, type 2
KW  - Glycated hemoglobin
KW  - Metformin
KW  - Insulin
KW  - Blood Glucose
KW  - Body mass index
KW  - Propensity score
KW  - Hypoglycemia
KW  - Weight gain
KW  - Fasting
TI  - Efficacy and Safety of iGlarLixi, Fixed-Ratio Combination of Insulin Glargine and Lixisenatide, Compared with Basal-Bolus Regimen in Patients with Type 2 Diabetes: Propensity Score Matched Analysis.
TY  - research article
VL  - 11
ER  -